1 – 20 of 22
- show: 20
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
The role of RNA-binding proteins in the processing of mRNAs produced by carcinogenic papillomaviruses
(
- Contribution to journal › Scientific review
- 2020
-
Mark
Role of viral ribonucleoproteins in human papillomavirus type 16 gene expression
(
- Contribution to journal › Scientific review
-
Mark
Heterogeneous Nuclear Ribonucleoprotein A1 (hnRNP A1) and hnRNP A2 Inhibit Splicing to Human Papillomavirus 16 Splice Site SA409 through a UAG-Containing Sequence in the E7 Coding Region
(
- Contribution to journal › Article
- 2019
-
Mark
Short half-life of HPV16 E6 and E7 mRNAs sensitizes HPV16-positive tonsillar cancer cell line HN26 to DNA-damaging drugs
(
- Contribution to journal › Article
- 2018
-
Mark
HnRNP G prevents inclusion on the HPV16 L1 mRNAs of the central exon between splice sites SA3358 and SD3632
(
- Contribution to journal › Article
-
Mark
Adenosine causes read-through into the late region of the HPV16 genome in a guanosine-dependent manner
(
- Contribution to journal › Article
-
Mark
Role of the DNA damage response in human papillomavirus RNA splicing and polyadenylation
(
- Contribution to journal › Scientific review
- 2010
-
Mark
Cervical cytology biobanking in Europe
(
- Contribution to journal › Article
- 2009
-
Mark
Triage of women with equivocal or low-grade cervical cytology results: a meta-analysis of the HPV test positivity rate
(
- Contribution to journal › Scientific review
- 2007
-
Mark
HPV type-specific risks of high-grade CIN during 4 years of follow-up: A population-based prospective study
(
- Contribution to journal › Article
- 2005
-
Mark
Heparan sulfate proteoglycans interact exclusively with conformationally intact HPV L1 assemblies: Basis for a virus-like particle ELISA
(
- Contribution to journal › Article
- 2003
-
Mark
Reactivity to human papillomavirus type 16 L1 virus-like particles in sera from patients with genital cancer and patients with carcinomas at five different extragenital sites.
(
- Contribution to journal › Article
-
Mark
Moderate variation of the oncogenic potential among high-risk human papillomavirus types in gynecologic patients with cervical abnormalities.
(
- Contribution to journal › Article
-
Mark
Prostate cancer risk and serologic evidence of human papilloma virus infection: a population-based case-control study.
(
- Contribution to journal › Article
- 2002
-
Mark
A population-based prospective study of Chlamydia trachomatis infection and cervical carcinoma.
(
- Contribution to journal › Article
-
Mark
A prospective study of the relationship between prediagnostic human papillomavirus seropositivity and HPV DNA in subsequent cervical carcinomas.
(
- Contribution to journal › Article
-
Mark
Herpes simplex virus and risk of cervical cancer: a longitudinal, nested case-control study in the nordic countries.
(
- Contribution to journal › Article
-
Mark
Evaluation of antibodies to human papillomavirus as prognostic markers in cervical cancer patients.
(
- Contribution to journal › Article
-
Mark
Human papillomavirus infection as a risk factor for anal and perianal skin cancer in a prospective study.
(
- Contribution to journal › Article
-
Mark
Clustering of seropositivities for sexually transmitted infections.
(
- Contribution to journal › Article